RegASK Platform
RegASK Website
Contents
x
eGuidebook
Substance Assessments
Specific Assessments
Italy
14 Articles
in this category
Share it
Share
Dark
Light
Contents
Italy
14 Articles
in this category
Share
Dark
Light
0. Record of Amendments
DCT Feasibility Assessment Italy The below version control table serves to document all updates made to the guidebook. The purpose is to ensure the information is always accurate and up-to-date. Disclaimers ...
1. Executive Summary
This workbook provides an overview of the current and proposed regulatory landscape applicable in Italy in relation to Decentralized Clinical Trials (“DCT”). It supplements the regulations applicable to the EU and EEA described in the European Medi...
2. General Questions
2.1 Name of Regulatory Authority Italian Medicines Agency/Agenzia Italiana del Farmaco (“AIFA”) AIFA , the competent authority in Italy, is responsible for all aspects concerning the investigation (authorization and monitoring of clinical...
3. Ethics Committee (EC)/ Institutional Review Board (IRB)
3.1 Provide a list of documents needed to be submitted for EC/IRB review and approval including the number of copies and/or translations as relevant. As per Art 2(5) of the Ministry of Health Decree 27 Jan 2023 : “The documentation r...
4. Regulatory Authority (RA)/ Competent Authority (CA)
4.1 Provide a list of documents needed to be submitted for RA/CA review and approval including the number of copies and/or translations as relevant. The following electronic documents are required to be submitted via CTIS (the EU’s Clinic...
5. Investigator and Investigational Product
5.1 Does local regulation require PI/CI to be approved/registered by any health authority (e.g., RA/EC)? The sponsor must submit an application to the Ethics Committee competent for the clinical site, which will include details of the pr...
6. Biological specimen
6.1 Provide a list of documents needed for export permit relevant to biological specimen shipment. The TARIC (Tarif Intégré de la Communauté) assists with determining if a license is required for a particular product. The TARIC is a multiling...
7. Decentralized Clinical Trials
7.1 Do the country regulations allow Decentralized Clinical Trials (DCT) elements (e.g., eConsent, ePRO administration, remote investigator site, etc.)? Yes . 7.2 Is there any specific regulation/guidance on the use of DCT el...
8. Data management
8.1 What data privacy and/or technology regulations need to be complied with to run a trial in the countries of interest? Primarily, the GDPR and the Italian Data Protection Code (DPC) (Legislative Decree no.101 of 10 Aug 2018) need to ...
9. Subject considerations
9.1 Clinical trial subject recruitment: Are digital advertisements (including social media streams such as TikTok) allowed and, if so, what regulations govern them ? Yes , subject to compliance with the appropriate EMA rules. No natio...
10. Roadmap of the submission process of a Clinical Trial
10.1 Clinical Trial with Investigational Medicinal Product The submission process using CTIS is described in more detail below this flowchart/road map: Training is to be prioritized for relevant staff in Italy on the use of the Clinical...
11. Regulatory Overview - DCT Components
12. Resources (listed in descending order of precedence)
Europe EU Clinical Trial Regulation (EU CTR) 536/2014 https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02014R0536-20220131 EMA- Questions and Answers Document Regulation (EU) 536/2014 https://health.ec.europa.eu/medicina...
13. Forms
Not applicable.